Michael S. Tute
Pfizer (United Kingdom)(GB)
Publications by Year
Research Areas
Computational Drug Discovery Methods, Synthesis and biological activity, Synthesis and Biological Evaluation, Protein Structure and Dynamics, Analytical Chemistry and Chromatography
Most-Cited Works
- → Glossary of Terms Used in Computational Drug Design (IUPAC Recommendations 1997)(1998)84 cited
- → Novel Selective Inhibitors of Neutral Endopeptidase for the Treatment of Female Sexual Arousal Disorder. Synthesis and Activity of Functionalized Glutaramides(2006)38 cited
- → Inhibition of viral neuraminidase by 1-phenoxymethyl-3,4-dihydroisoquinolines. II. Hansch analysis(1970)24 cited
- → 1,3-Diamino-6,7-dimethoxyisoquinoline derivatives as potential .alpha.1-adrenoceptor antagonists(1988)22 cited
- → Empirical methods for computing molecular partition coefficients: II. Inclusion of conformational flexibility within fragment–based approaches(1992)18 cited
- → Empirical methods for computing molecular partition coefficients. I. Upon the need to model the specific hydration of polar groups in fragment-based approaches(1991)14 cited
- → Inhibition of viral neuraminidase by 1-phenoxymethyl-3,4-dihydroisoquinolines. I. Steric effects(1970)14 cited
- → A Cellular Automata Model of Acid Dissociation(1998)13 cited
- → Computer Modelling and Information Technology(1991)6 cited
- → Thromboxane modulating agents. 2. Thromboxane receptor antagonists derived from the thromboxane synthase inhibitor dazmegrel.(1996)4 cited